back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-27 16:57 Tx date 2024-03-25 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$451,999
+50,000 vol $9.04 each |
156,000 | |
| Filed 2022-10-27 13:29 Tx date 2022-06-29 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
106,000 | |
| Filed 2020-12-14 18:45 Tx date 2020-12-11 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$115,500
+16,500 vol $7.00 each |
83,500 | |
| Filed 2019-11-01 15:32 Tx date 2019-10-30 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$116,750
+25,000 vol $4.67 each |
67,000 | |
| Filed 2019-10-16 13:13 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,750
+25,000 vol $3.23 each |
42,000 | |
| Filed 2019-10-16 13:09 Tx date 2019-10-07 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$80,750
+25,000 vol $3.23 each |
||
| Filed 2019-02-12 Tx date 2019-02-08 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,299
+5,000 vol $5.06 each |
17,000 | |
| Filed 2018-04-26 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-228,000 vol |
12,000 | |
| Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$29,400
+120,000 vol $0.245 each |
240,000 | |
| Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$29,400
+120,000 vol $0.245 each |
120,000 | |
| Filed 2018-03-06 Tx date 2018-02-21 |
$EPI
ESSA Pharma Inc. |
Sollis, Gary Ralph
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-96,000
-120,000 vol $0.80 each |
0 |